Publication:
Real World Efficacy and Safety of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis

Simple item page
dc.contributor.authorBoz, C.
dc.contributor.authorOzakbas, S.
dc.contributor.authorTerzi, M.
dc.contributor.authorTurkoglu, R.
dc.contributor.authorAkman, G.
dc.contributor.authorEfendi, H.
dc.contributor.authorAltunrende, B.
dc.contributor.authorIDDEMIRKIRAN, Meltem/0000-0002-4649-5315
dc.contributor.authorIDTurkoglu, Recai/0000-0001-9724-851X
dc.contributor.authorIDAltintas, Ayse/0000-0002-8524-5087
dc.contributor.authorIDAKCALI, Aylin/0000-0002-3614-1046
dc.date.accessioned2020-06-21T13:18:02Z
dc.date.available2020-06-21T13:18:02Z
dc.date.issued2017
dc.departmentOMÜen_US
dc.department-temp[Boz, C.] Karadeniz Tech Univ, Fac Med, Neurol, Trabzon, Turkey -- [Ozakbas, S.] Dokuz Eylul Univ, Fac Med, Neurol, Izmir, Turkey -- [Terzi, M.] Ondokuz Mayis Univ, Fac Med, Neurol, Trabzon, Turkey -- [Turkoglu, R.] Haydarpasa Numune Training & Res Hosp, Neurol, Istanbul, Turkey -- [Akman, G. -- Altunrende, B.] Bilim Univ, Fac Med, Neurol, Istanbul, Turkey -- [Efendi, H.] Kocaeli Univ, Fac Med, Neurol, Kocaeli, Turkeyen_US
dc.description7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) -- OCT 25-28, 2017 -- Paris, FRANCEen_US
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosisen_US
dc.description.sponsorshipMerckMerck & Company; NovartisNovartis; Bayer-ScheringBayer AG; Tevaen_US
dc.description.sponsorshipMurat Terzi received travel grants from Merck, Novartis, Bayer-Schering, Merck and Teva; has participated in clinical trials by Sanofi Aventis, Roche and Novartis.en_US
dc.identifier.endpage328en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage327en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/12183
dc.identifier.volume23en_US
dc.identifier.wosWOS:000413730202068
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal World Efficacy and Safety of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosisen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu